Dai, Xiao-li <br/><br/>
Efficacy and prognosis of neoadjuvant chemotherapy is correlated with breast cancer molecular classification.  [electronic resource] 

 -  International journal of clinical pharmacology and therapeutics  Jul 2015 
 - 517-22 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0946-1965 
<br/><br/><label>Standard No.: </label>10.5414/CP202327  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Tumor--analysis<br/>Breast Neoplasms--chemistry<br/>Chemotherapy, Adjuvant<br/>Chi-Square Distribution<br/>Disease Progression<br/>Disease-Free Survival<br/>Docetaxel<br/>Epirubicin--administration & dosage<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Neoadjuvant Therapy<br/>Neoplasm Grading<br/>Precision Medicine<br/>Predictive Value of Tests<br/>Receptor, ErbB-2--analysis<br/>Receptors, Estrogen--analysis<br/>Receptors, Progesterone--analysis<br/>Remission Induction<br/>Risk Factors<br/>Taxoids--administration & dosage<br/>Time Factors<br/>Treatment Outcome